Hypnotic and cardiovascular effects of proprietary and generic propofol formulations do not differ

Citation
A. Fassoulaki et al., Hypnotic and cardiovascular effects of proprietary and generic propofol formulations do not differ, CAN J ANAES, 48(5), 2001, pp. 459-461
Citations number
7
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Journal title
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE
ISSN journal
0832610X → ACNP
Volume
48
Issue
5
Year of publication
2001
Pages
459 - 461
Database
ISI
SICI code
0832-610X(200105)48:5<459:HACEOP>2.0.ZU;2-3
Abstract
Purpose: The aim of the study was to compare the potency of two different p ropofol formulations: proprietary and generic propofol using the bispectral index (BIS) monitoring. Methods: Forty female patients undergoing breast surgery received propofol 3 mg(.)kg(-1) followed by propofol infusion adjusted to maintain a 40% BIS value, supplemented by 50% nitrous oxide. Proprietary or generic propofol w as administered in a randomized double-blind manner. Results: The propofol mg/BIS% ratio obtained after the bolus dose, the cumu lative infused propofol mg/BIS% ratio at the end of each five-minute interv al and the total dose of propofol administered as bolus + infusion were sim ilar between the two groups. The two groups did not differ with regard to s ystolic and diastolic blood pressure, heart rate, end-tidal carbon dioxide and arterial oxygen saturation. Conclusion: The two propofol formulations are equipotent when hypnotic effe ct is assessed by BIS monitoring.